4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-053382
Options or other derivatives
- Chief Accounting Officer acquired 50,262 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-10 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +50,262 | 50,262 | D |
Loading xslF345X05/ownership.xml…